Cargando…
MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. In recent years, a new form...
Autores principales: | de Araújo, Helena Varela, Sakamoto, Luis Henrique Toshihiro, Bacal, Nydia Strachman, Epelman, Sidnei, Real, Juliana Monte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868825/ https://www.ncbi.nlm.nih.gov/pubmed/35303052 http://dx.doi.org/10.31744/einstein_journal/2022RB5954 |
Ejemplares similares
-
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016) -
MBRS-66. COST-EFFECTIVE METHOD TO INCORPORATE MOLECULAR CLASSIFICATION OF MEDULLOBLASTOMA INTO A LATIN-AMERICAN CLINICAL TRIAL
por: Epelman, Sidnei, et al.
Publicado: (2020) -
LGG-51. BRAF ALTERATIONS IN PEDIATRIC LOW-GRADE GLIOMAS: RESULTS FROM A BRAZILIAN COHORT
por: Restine, Felipe, et al.
Publicado: (2020) -
Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia
por: Correia, Rodolfo Patussi, et al.
Publicado: (2014) -
DIPG-72. LONG-TERM SURVIVAL OF A CLASSIC DIFFUSE INTRINSIC PONTINE GLIOMA TREATED WITH NIMOTUZUMAB
por: Epelman, Sidnei, et al.
Publicado: (2020)